Lactobacillus paracasei strain
US-12152232-B2 · Nov 26, 2024 · US
Lactobacillus plantarum and composition containing same
US9572846B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9572846-B2 |
| Application number | US-200913380129-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 1, 2009 |
| Priority date | Jul 14, 2009 |
| Publication date | Feb 21, 2017 |
| Grant date | Feb 21, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides Lactobacillus plantarum CJLP55 KCTC 11401BP, a composition for treating bowel disease containing the lactobacillus , and a composition for immunological enhancement containing the lactobacillus.
First claim
Opening claim text (preview).
The invention claimed is: 1. A bacterial composition, comprising: Lactobacillus plantarum CJLP55 KCTC 11401BP; and an effective amount of a cryoprotectant, wherein the bacterial composition is a freeze-dried composition. 2. The bacterial composition of claim 1 , wherein the cryoprotectant comprises one or more selected from the group consisting of glycerol, skim milk and dextrin. 3. The composition of claim 1 , suitable for use in treatment of enteropathy. 4. The composition of claim 3 , wherein the enteropathy is selected from the group consisting of infectious diarrhea caused by pathogenic microorganisms, gastroenteritis, inflammatory bowel disease, psychogenic enteritis syndrome, overgrowth of microorganisms in the small intestine and non-infectious diarrhea. 5. The composition of claim 1 , suitable for use in treatment of immune disease. 6. The composition of claim 5 , wherein the immune disease is selected from the group consisting of allergic diseases, atopy and autoimmune diseases. 7. A pharmaceutical composition, comprising the bacterial composition of claim 1 and a suitable pharmaceutically acceptable excipient or additive. 8. The pharmaceutical composition of claim 7 , wherein a formulation of the pharmaceutical composition is selected from the group consisting of powder, granules, tablets, capsules, pills and extracts. 9. A health functional food composition, comprising the bacterial composition of claim 1 and a sitologically acceptable excipient or additive. 10. A food composition, comprising the bacterial composition of claim 1 and a food. 11. The food composition of claim 10 , further comprising a sitologically acceptable excipient or additive. 12. A livestock feed composition, comprising the bacterial composition of claim 1 and a livestock feed. 13. A livestock feed additive, comprising the bacterial composition of claim 1 and an organic acid or a natural antioxidant. 14. A cosmetic, comprising the bacterial composition of claim 1 and a cosmetic excipient or additive. 15. A stabilized composition, comprising the bacterial composition of claim 1 and a stabilizer. 16. The stabilized composition of claim 15 , wherein the stabilizer is selected from the group consisting of sodium carboxymethylcellulose, β-cyclodextrin, white wax and xanthan gum.
Assignees
Inventors
Classifications
Immunostimulants · CPC title
Antineoplastic agents · CPC title
Immunosuppressants, e.g. drugs for graft rejection · CPC title
Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title
Drugs for immunological or allergic disorders · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9572846B2 cover?
- The present invention provides Lactobacillus plantarum CJLP55 KCTC 11401BP, a composition for treating bowel disease containing the lactobacillus , and a composition for immunological enhancement containing the lactobacillus.
- Who is the assignee on this patent?
- Kim Bong Joon, Jung Heon Woong, Koh Ji Hoon, and 5 more
- What technology area does this patent fall under?
- Primary CPC classification A61K35/747. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).